Fluticasone/salmeterol 55/14mcg In

Manufacturer TEVA PHARMACEUTICALS USA Active Ingredient Fluticasone and Salmeterol Inhalation Powder(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Some brands are used to treat COPD (chronic obstructive pulmonary disease).It may be given to you for other reasons. Talk with the doctor.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Antiasthmatic; Bronchodilator, Adrenal Corticosteroid
🧬
Pharmacologic Class
Inhaled corticosteroid (ICS); Long-acting beta2-adrenergic agonist (LABA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jul 2016
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medicine is an inhaler that contains two different medications: a steroid (fluticasone) and a long-acting bronchodilator (salmeterol). The steroid helps reduce swelling and inflammation in your lungs, making it easier to breathe. The bronchodilator helps open up your airways for a longer time. It's used regularly, usually twice a day, to prevent asthma attacks or improve breathing in COPD, but it is NOT for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only. Continue using it as directed by your doctor or healthcare provider, even if you feel well. Take it at the same time every day to establish a routine.

After each use, rinse your mouth with water, but do not swallow the water. Instead, spit it out. If you are using multiple inhaled medications, consult your doctor about which one to use first.

Preparing and Taking a Dose

Only prepare a dose when you are ready to take it. If you prepare a dose and then close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged. When taking a dose, do not breathe out into the inhaler. Close the inhaler after use. If you do not taste or feel the powder, do not take an extra dose.

Caring for Your Inhaler

Do not take the inhaler apart or wash it, and do not use it with a spacer. To clean the mouthpiece, gently wipe it with a dry tissue or cloth. Avoid washing the mouthpiece or putting it in water.

Tracking Your Doses

The inhaler has a built-in dose counter to help you keep track of how many doses are left. Once the counter reaches "0," or after one month from opening the foil pouch, or when the expiration date is reached (whichever comes first), discard the inhaler.

Storage and Disposal

Store the medication at room temperature in a dry place, avoiding bathrooms. Keep it in the foil pouch until you are ready to use it.

What to Do If You Miss a Dose

If you miss a dose, skip it and return to your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
πŸ’‘

Lifestyle & Tips

  • Use this medicine regularly, exactly as prescribed, even if you feel well. Do not stop using it without talking to your doctor.
  • This is a maintenance medicine, not a rescue inhaler. Always carry your fast-acting rescue inhaler (e.g., albuterol) for sudden breathing problems.
  • Rinse your mouth with water and spit it out after each dose to help prevent a fungal infection (thrush) in your mouth and throat.
  • Do not exceed the prescribed dose. Using too much can be dangerous.
  • Avoid exposure to asthma triggers (e.g., allergens, smoke, pollution).
  • Maintain good hydration and nutrition.
  • Regular exercise, as tolerated, can improve lung function and overall health.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 1 inhalation (fluticasone 55 mcg/salmeterol 14 mcg) twice daily, approximately 12 hours apart
Dose Range: 55 - 232 mg

Condition-Specific Dosing:

asthma_maintenance: 1 inhalation (fluticasone 55 mcg/salmeterol 14 mcg) twice daily, approximately 12 hours apart. For patients not adequately controlled on an ICS or whose disease warrants initiation of both an ICS and LABA.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this strength below 12 years of age. For children 12 years and older with asthma: 1 inhalation (fluticasone 55 mcg/salmeterol 14 mcg) twice daily, approximately 12 hours apart.
Adolescent: 1 inhalation (fluticasone 55 mcg/salmeterol 14 mcg) twice daily, approximately 12 hours apart.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment recommended.
Moderate: No dosage adjustment recommended.
Severe: No dosage adjustment recommended.
Dialysis: No specific recommendations; systemic exposure is low.

Hepatic Impairment:

Mild: No dosage adjustment recommended.
Moderate: Use with caution; increased systemic exposure of fluticasone propionate and salmeterol may occur.
Severe: Use with caution; increased systemic exposure of fluticasone propionate and salmeterol may occur. Monitor for systemic corticosteroid effects and cardiovascular effects.

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways, decreasing hyperresponsiveness. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA). It selectively stimulates beta2-adrenergic receptors in the lungs, leading to relaxation of bronchial smooth muscle and bronchodilation. The combination provides both anti-inflammatory and bronchodilator effects.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: Low systemic bioavailability (<30% for inhaled dose due to extensive first-pass metabolism and incomplete oral absorption). Salmeterol: Low systemic bioavailability (<5% for inhaled dose).
Tmax: Fluticasone: 0.5-1 hour (inhaled). Salmeterol: 5-10 minutes (inhaled).
FoodEffect: Not applicable for inhaled powder.

Distribution:

Vd: Fluticasone: Approximately 318 L. Salmeterol: Approximately 153 L.
ProteinBinding: Fluticasone: 91%. Salmeterol: 96%.
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: Approximately 8 hours (terminal). Salmeterol: Approximately 5.5 hours (terminal).
Clearance: Fluticasone: High systemic clearance (1150 mL/min). Salmeterol: High systemic clearance (580 mL/min).
ExcretionRoute: Primarily fecal (fluticasone and salmeterol metabolites). Renal excretion is minor.
Unchanged: Fluticasone: <5% (urine). Salmeterol: <1% (urine).
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (bronchodilation). Fluticasone: Anti-inflammatory effects may take several days to weeks for full therapeutic benefit.
PeakEffect: Salmeterol: 1-2 hours. Fluticasone: Weeks for maximal anti-inflammatory effect.
DurationOfAction: Salmeterol: Approximately 12 hours. Fluticasone: Sustained anti-inflammatory effect with twice-daily dosing.

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial (SMART study) showed an increased risk of asthma-related deaths in patients receiving salmeterol. This finding is considered a class effect of LABAs. Therefore, fluticasone/salmeterol is not indicated for the primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required. It should not be used in patients whose asthma is adequately controlled on low- or medium-dose inhaled corticosteroids.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, severe dizziness or fainting, muscle weakness, extreme fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or excitable
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Changes in voice
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Breathing Problems: A Life-Threatening Side Effect

This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:

Headache
Upset stomach or vomiting
Throat irritation
* Signs of a common cold

This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for your rescue inhaler
  • Chest pain, fast or irregular heartbeat, or palpitations
  • Severe headache or dizziness
  • Tremor or nervousness
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • White patches in your mouth or throat (oral thrush)
  • Blurred vision or eye pain
  • Muscle cramps or weakness
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to discuss all of your medications (prescription and over-the-counter), natural products, vitamins, and health conditions with your doctor and pharmacist. They will help you determine whether it is safe to take this medication with your existing regimen.

Remember, do not start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Effectiveness and Monitoring
It may take approximately 1 week to experience the full effect of this medication. If you have diabetes (high blood sugar), consult your doctor, as this drug may increase blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.

Dosage and Administration
Do not exceed the prescribed dose or use this medication more often than recommended. Overdose can be fatal, so it is crucial to follow your doctor's instructions. If you have any concerns, discuss them with your doctor.

Transitioning from Oral Steroids
When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

Stressful Situations
In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in such situations.

Long-term Use
Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult your doctor about this potential risk. Additionally, have regular eye exams as recommended by your doctor.

Bone Health
Long-term use of this medication may also lead to weak bones (osteoporosis). Discuss your risk factors with your doctor and undergo bone density tests as advised.

Infection Risk
You may be more susceptible to infections while taking this medication. To minimize this risk, wash your hands frequently and avoid close contact with people who have infections, colds, or flu.

Viral Infections
If you have not had chickenpox or measles before, avoid exposure to these viruses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult your doctor immediately.

Special Populations
If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

Pediatric Use
In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so discuss this with your doctor.

Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to weigh the benefits and risks of this medication for you and your baby.

COPD
If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk, so discuss this with your doctor.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Salmeterol overdose: Tachycardia, palpitations, tremor, headache, nausea, dizziness, hypokalemia, hyperglycemia, chest pain, arrhythmias.
  • Fluticasone overdose: Acute overdose is unlikely due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (e.g., Cushingoid features, adrenal suppression).

What to Do:

Seek immediate medical attention or call a poison control center. For the US, call 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function and serum potassium levels.

Drug Interactions

🚫

Contraindicated Interactions

  • Other long-acting beta2-adrenergic agonists (LABAs) - risk of overdose.
  • Non-selective beta-blockers (e.g., propranolol) - may block the bronchodilatory effect of salmeterol and produce severe bronchospasm in patients with asthma.
πŸ”΄

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, cobicistat-containing products) - significantly increase systemic exposure to fluticasone and salmeterol, leading to increased risk of systemic corticosteroid effects (e.g., Cushing's syndrome, adrenal suppression) and cardiovascular effects (e.g., QT prolongation, palpitations, tachycardia) from salmeterol.
  • Diuretics (e.g., loop or thiazide diuretics) - may potentiate ECG changes and/or hypokalemia associated with beta-agonists, especially at high doses.
🟑

Moderate Interactions

  • Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) - may potentiate the effect of salmeterol on the cardiovascular system, increasing the risk of arrhythmias. Use with extreme caution.
  • Other sympathomimetics - may potentiate adverse cardiovascular effects.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Asthma/COPD Control Assessment

Rationale: To evaluate baseline symptom frequency, severity, and impact on daily life.

Timing: Prior to initiation of therapy.

Oral Cavity Examination

Rationale: To check for existing oral candidiasis.

Timing: Prior to initiation of therapy.

Electrolytes (Potassium)

Rationale: Salmeterol can cause transient hypokalemia.

Timing: Consider in patients at risk for hypokalemia.

Blood Glucose

Rationale: Salmeterol can cause transient hyperglycemia.

Timing: Consider in diabetic patients.

πŸ“Š

Routine Monitoring

Asthma/COPD Symptoms and Rescue Inhaler Use

Frequency: Regularly (e.g., at each follow-up visit)

Target: Improved symptom control, decreased rescue inhaler use.

Action Threshold: Worsening symptoms, increased rescue inhaler use, or lack of improvement may indicate inadequate control or need for re-evaluation.

Pulmonary Function Tests (e.g., FEV1)

Frequency: Periodically (e.g., every 3-12 months, or as clinically indicated)

Target: Maintenance or improvement of lung function.

Action Threshold: Decline in FEV1 may indicate worsening disease or inadequate therapy.

Oral Cavity Inspection

Frequency: Regularly (e.g., at each follow-up visit)

Target: Absence of oral candidiasis.

Action Threshold: Presence of thrush requires antifungal treatment and reinforcement of rinsing mouth after use.

Growth (in pediatric patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity.

Action Threshold: Growth retardation may indicate systemic corticosteroid effects; consider lowest effective dose.

Signs of Systemic Corticosteroid Effects (e.g., adrenal suppression, bone density, cataracts/glaucoma)

Frequency: Periodically, especially with long-term use or high doses.

Target: Absence of signs/symptoms.

Action Threshold: Presence of signs/symptoms requires evaluation and potential dose adjustment or alternative therapy.

Electrolytes (Potassium) and Blood Glucose

Frequency: Periodically, especially in patients with comorbidities (e.g., diabetes, cardiovascular disease) or on concomitant medications (e.g., diuretics).

Target: Within normal limits.

Action Threshold: Significant abnormalities require intervention.

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma/COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for rescue inhaler (e.g., albuterol)
  • Chest pain or palpitations
  • Tremor or nervousness
  • Oral thrush (white patches in mouth/throat)
  • Blurred vision or eye pain (rare, related to glaucoma/cataracts)
  • Signs of infection (e.g., fever, increased sputum production)

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Both fluticasone and salmeterol have shown teratogenic effects in animal studies at high doses.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity observed in animal studies at high doses; human data limited.
Second Trimester: Continued monitoring of asthma control is crucial. Uncontrolled asthma poses risks to both mother and fetus.
Third Trimester: Monitor for signs of fetal adrenal suppression if high doses of fluticasone are used, though systemic absorption is low.
🀱

Lactation

L3 (Moderately Safe). It is not known whether fluticasone propionate or salmeterol are excreted in human milk. However, other corticosteroids and beta2-agonists are excreted. Caution should be exercised when fluticasone/salmeterol is administered to a nursing woman. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for the drug and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition.

Infant Risk: Low risk of adverse effects due to low systemic absorption in the mother and high protein binding, limiting transfer into milk. Monitor infant for signs of systemic corticosteroid effects (e.g., growth suppression) or beta-agonist effects (e.g., irritability, tremor), though unlikely.
πŸ‘Ά

Pediatric Use

Safety and effectiveness in pediatric patients younger than 12 years of age have not been established for this strength. For patients 12 years and older, monitor growth velocity regularly. Risk of systemic corticosteroid effects (e.g., adrenal suppression, growth retardation) should be considered, especially with long-term use. Use the lowest effective dose.

πŸ‘΄

Geriatric Use

No dosage adjustment is generally required. However, elderly patients may be more susceptible to the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension) and systemic corticosteroid effects. Monitor for comorbidities and concomitant medications.

Clinical Information

πŸ’Ž

Clinical Pearls

  • This medication is for maintenance treatment only and should not be used for acute bronchospasm. Patients should have a rescue inhaler readily available.
  • Proper inhalation technique is critical for drug delivery. Patients should be instructed and periodically re-evaluated on their technique.
  • Rinsing the mouth and spitting out water after each dose helps prevent oral candidiasis (thrush).
  • Patients should be warned about the black box warning regarding the increased risk of asthma-related death with LABAs, and that this product should not be used as monotherapy for asthma.
  • Do not stop therapy abruptly, especially if on high doses, due to the risk of adrenal insufficiency from the corticosteroid component.
  • Monitor for signs of systemic corticosteroid effects, especially in children (growth) and with long-term use.
πŸ”„

Alternative Therapies

  • Inhaled Corticosteroid (ICS) monotherapy (e.g., fluticasone propionate, budesonide)
  • Long-acting muscarinic antagonist (LAMA) (e.g., tiotropium, umeclidinium) - for COPD
  • Leukotriene receptor antagonists (LTRAs) (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations)
  • Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $200-$400+ per inhaler (e.g., 60 or 120 doses)
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (preferred brand or non-preferred brand, depending on plan). Generic versions are typically Tier 1 or 2.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to ensure you receive the best possible care.